# Bupropion SR Plus Counseling for Smoking Cessation

> **NCT01621009** · PHASE4 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 463 (actual)

## Conditions studied

- Tobacco Dependence
- Smoking

## Interventions

- **DRUG:** Active bupropion + counseling
- **DRUG:** Active bupropion, No counseling
- **DRUG:** Placebo medication + counseling
- **DRUG:** Placebo medication, No counseling

## Key facts

- **NCT ID:** NCT01621009
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2002-10
- **Final completion:** 2003-10
- **Target enrollment:** 463 (ACTUAL)
- **Last updated:** 2016-01-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621009, "Bupropion SR Plus Counseling for Smoking Cessation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01621009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*